Skip to main content
Top
Published in: Nutrition & Metabolism 1/2012

Open Access 01-12-2012 | Research

Using 3–6 differences in essential fatty acids rather than 3/6 ratios gives useful food balance scores

Authors: Bill Lands, Etienne Lamoreaux

Published in: Nutrition & Metabolism | Issue 1/2012

Login to get access

Abstract

Background

The vitamin-like omega-3 and omega-6 essential fatty acids are converted in the body to a large family of hormones which act at selective receptors that occur on nearly every cell and tissue. A relative omega-3 deficit allows overabundant actions of omega-6 hormones to develop into health disorders. People need simple, explicit information on the balance of essential fatty acids in their foods to avoid accumulating unintended imbalances in their tissue omega-3 and omega-6 fatty acids.

Results

We developed an Omega 3–6 Balance Food Score that summarizes in a single value the balance among eleven omega-3 and omega-6 essential fatty acids in a food. The value allows a quantitative estimate of the impact of each food item on the proportions of omega-3 and omega-6 that will accumulate in the 20- and 22-carbon highly unsaturated fatty acids of blood, which is an important health risk assessment biomarker.

Conclusions

The impact of an individual food item upon a useful health risk assessment biomarker is easily evident in a simple, explicit value for the balance among eleven essential fatty acids nutrients. Foods with more positive Omega 3–6 Balance Food Scores will increase the percent of omega-3 in the biomarker, whereas those with more negative Scores will increase the percent of omega-6 in the biomarker.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wada M, DeLong CJ, Hong YH, Rieke CJ, Song I, Sidhu RS, Yuan C, Warnock M, Schmaier AH, Yokoyama C, Smyth EM, Wilson SJ, FitzGerald GA, Garavito RM, Sui DX, Regan JW, Smith WL: Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products. J Biol Chem. 2007, 282 (31): 22254-22266. 10.1074/jbc.M703169200.CrossRef Wada M, DeLong CJ, Hong YH, Rieke CJ, Song I, Sidhu RS, Yuan C, Warnock M, Schmaier AH, Yokoyama C, Smyth EM, Wilson SJ, FitzGerald GA, Garavito RM, Sui DX, Regan JW, Smith WL: Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products. J Biol Chem. 2007, 282 (31): 22254-22266. 10.1074/jbc.M703169200.CrossRef
2.
go back to reference Culp BR, Lands WEM, Lucchesi BR, Pitt B, Romson J: The effect of dietary supplementation of fish oil on experimental myocardial infarction. Prostaglandins. 1980, 20: 1021-1031.CrossRef Culp BR, Lands WEM, Lucchesi BR, Pitt B, Romson J: The effect of dietary supplementation of fish oil on experimental myocardial infarction. Prostaglandins. 1980, 20: 1021-1031.CrossRef
3.
go back to reference Lands WEM: Biosynthesis of Prostaglandins. Ann Rev Nutr. 1991, 11: 41-60. 10.1146/annurev.nu.11.070191.000353.CrossRef Lands WEM: Biosynthesis of Prostaglandins. Ann Rev Nutr. 1991, 11: 41-60. 10.1146/annurev.nu.11.070191.000353.CrossRef
4.
go back to reference Lands WEM: Functional foods in primary prevention or nutraceuticals in secondary prevention?. Current Topics in Nutraceutical Research. 2003, 1 (2): 113-120. Lands WEM: Functional foods in primary prevention or nutraceuticals in secondary prevention?. Current Topics in Nutraceutical Research. 2003, 1 (2): 113-120.
5.
go back to reference Mohrhauer H, Holman RT: The effect of dose level of essential fatty acids upon fatty acid composition of the rat liver. J Lipid Res. 1963, 4: 151-159. Mohrhauer H, Holman RT: The effect of dose level of essential fatty acids upon fatty acid composition of the rat liver. J Lipid Res. 1963, 4: 151-159.
6.
go back to reference Mohrhauer H, Holman RT: Effect of linolenic acid upon the metabolism of linoleic acid. J Nutr. 1963, 81: 67-74. Mohrhauer H, Holman RT: Effect of linolenic acid upon the metabolism of linoleic acid. J Nutr. 1963, 81: 67-74.
7.
go back to reference Lands WEM, Morris AJ, Libelt B: Quantitative effects of dietary polyunsaturated fats on the composition of fatty acids in rat tissues. Lipids. 1990, 25: 505-516. 10.1007/BF02537156.CrossRef Lands WEM, Morris AJ, Libelt B: Quantitative effects of dietary polyunsaturated fats on the composition of fatty acids in rat tissues. Lipids. 1990, 25: 505-516. 10.1007/BF02537156.CrossRef
8.
go back to reference Lands WEM, Libelt B, Morris A, Kramer NC, Prewitt TE, Bowen P, Schmeisser D, Davidson MH, Burns JH: Maintenance of lower proportions of n-6 eicosanoid precursors in phospholipids of human plasma in response to added dietary n-3 fatty acids. Biochem Biophys Acta. 1992, 1180: 147-162. 10.1016/0925-4439(92)90063-S. Lands WEM, Libelt B, Morris A, Kramer NC, Prewitt TE, Bowen P, Schmeisser D, Davidson MH, Burns JH: Maintenance of lower proportions of n-6 eicosanoid precursors in phospholipids of human plasma in response to added dietary n-3 fatty acids. Biochem Biophys Acta. 1992, 1180: 147-162. 10.1016/0925-4439(92)90063-S.
10.
go back to reference Stark KD: The percentage of n-3 highly unsaturated fatty acids in total HUFA as a biomarker for omega-3 fatty acid status in tissues. Lipids. 2008, 43: 45-53. 10.1007/s11745-007-3128-3.CrossRef Stark KD: The percentage of n-3 highly unsaturated fatty acids in total HUFA as a biomarker for omega-3 fatty acid status in tissues. Lipids. 2008, 43: 45-53. 10.1007/s11745-007-3128-3.CrossRef
11.
go back to reference Metherel AH, Armstrong JM, Patterson AC, Stark KD: Assessment of blood measures of n-3 polyunsaturated fatty acids with acute fish oil supplementation and washout in men and women. Prostaglandins Leukot Essent Fatty Acids. 2009, 81 (1): 23-29. 10.1016/j.plefa.2009.05.018.CrossRef Metherel AH, Armstrong JM, Patterson AC, Stark KD: Assessment of blood measures of n-3 polyunsaturated fatty acids with acute fish oil supplementation and washout in men and women. Prostaglandins Leukot Essent Fatty Acids. 2009, 81 (1): 23-29. 10.1016/j.plefa.2009.05.018.CrossRef
12.
go back to reference Lands B: Measuring blood fatty acids as a surrogate indicator for coronary heart disease risk in population studies. World Rev Nutr Diet. 2009, 100: 22-34.CrossRef Lands B: Measuring blood fatty acids as a surrogate indicator for coronary heart disease risk in population studies. World Rev Nutr Diet. 2009, 100: 22-34.CrossRef
13.
go back to reference Strandjord SE, Lands B, Hibbeln JR: Validation of an equation predicting highly unsaturated fatty acid compositions of human blood fractions from dietary intake. Submitted to Nutrition and Metabolism. Strandjord SE, Lands B, Hibbeln JR: Validation of an equation predicting highly unsaturated fatty acid compositions of human blood fractions from dietary intake. Submitted to Nutrition and Metabolism.
17.
go back to reference Lands WEM: Diets could prevent many diseases. Lipids. 2003, 38 (4): 317-321. 10.1007/s11745-003-1066-0.CrossRef Lands WEM: Diets could prevent many diseases. Lipids. 2003, 38 (4): 317-321. 10.1007/s11745-003-1066-0.CrossRef
18.
go back to reference Lands WEM: Fish, Omega-3 and Human Health. 2005, AOCS Press: Champaign, 2 Lands WEM: Fish, Omega-3 and Human Health. 2005, AOCS Press: Champaign, 2
19.
go back to reference Lands B: A critique of paradoxes in current advice on dietary lipids. Prog Lipid Res. 2008, 47 (2): 77-106. 10.1016/j.plipres.2007.12.001.CrossRef Lands B: A critique of paradoxes in current advice on dietary lipids. Prog Lipid Res. 2008, 47 (2): 77-106. 10.1016/j.plipres.2007.12.001.CrossRef
20.
go back to reference Alvheim AR, Malde MK, Osei-Hyiaman D, Hong Lin Y, Pawlosky RJ, Madsen L, Kristiansen K, Frøyland L, Hibbeln JR: Dietary Linoleic Acid Elevates Endogenous 2-AG and Anandamide and Induces Obesity. Obesity (Silver Spring). 2012, 10.1038/oby.2012.38.. [Epub ahead of print] PubMed PMID: 22334255 Alvheim AR, Malde MK, Osei-Hyiaman D, Hong Lin Y, Pawlosky RJ, Madsen L, Kristiansen K, Frøyland L, Hibbeln JR: Dietary Linoleic Acid Elevates Endogenous 2-AG and Anandamide and Induces Obesity. Obesity (Silver Spring). 2012, 10.1038/oby.2012.38.. [Epub ahead of print] PubMed PMID: 22334255
21.
go back to reference Hibbeln JR, Nieminen LR, Blasbalg TL, Riggs JA, Lands WE: Healthy intakes of n-3 and n-6 fatty acids: estimations considering worldwide diversity. Am J Clin Nutr. 2006, 83 (6 Suppl): 1483S-1493S. Hibbeln JR, Nieminen LR, Blasbalg TL, Riggs JA, Lands WE: Healthy intakes of n-3 and n-6 fatty acids: estimations considering worldwide diversity. Am J Clin Nutr. 2006, 83 (6 Suppl): 1483S-1493S.
22.
go back to reference Freeman MP, Hibbeln JR, Wisner KL, Davis JM, Mischoulon D, Peet M, Keck PE, Marangell LB, Richardson AJ, Lake J, Stoll AL: Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry. 2006, 67 (12): 1954-1967. 10.4088/JCP.v67n1217.CrossRef Freeman MP, Hibbeln JR, Wisner KL, Davis JM, Mischoulon D, Peet M, Keck PE, Marangell LB, Richardson AJ, Lake J, Stoll AL: Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry. 2006, 67 (12): 1954-1967. 10.4088/JCP.v67n1217.CrossRef
23.
go back to reference Wei C, Hua J, Bin C, Klassen K: Impact of lipid emulsion containing fish oil on outcomes of surgical patients: systematic review of randomized controlled trials from Europe and Asia. Nutrition. 2010, 26 (5): 474-81. 10.1016/j.nut.2009.09.011.CrossRef Wei C, Hua J, Bin C, Klassen K: Impact of lipid emulsion containing fish oil on outcomes of surgical patients: systematic review of randomized controlled trials from Europe and Asia. Nutrition. 2010, 26 (5): 474-81. 10.1016/j.nut.2009.09.011.CrossRef
24.
go back to reference Lands B: Prevent the cause, not just the symptoms. Prostaglandins Other Lipid Mediat. 2011, 96: 90-93. 10.1016/j.prostaglandins.2011.07.003.CrossRef Lands B: Prevent the cause, not just the symptoms. Prostaglandins Other Lipid Mediat. 2011, 96: 90-93. 10.1016/j.prostaglandins.2011.07.003.CrossRef
27.
go back to reference Blasbalg TL, Hibbeln JR, Ramsden CE, Majchrzak SF, Rawlings RR: Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. Am J Clin Nutr. 2011, 93 (5): 950-962. 10.3945/ajcn.110.006643.CrossRef Blasbalg TL, Hibbeln JR, Ramsden CE, Majchrzak SF, Rawlings RR: Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. Am J Clin Nutr. 2011, 93 (5): 950-962. 10.3945/ajcn.110.006643.CrossRef
28.
go back to reference Ramsden CE, Hibbeln JR, Majchrzak SF, Davis JM: n-6 fatty acid-specific and mixed polyunsaturate dietary interventions have different effects on CHD risk: a meta-analysis of randomised controlled trials. Br J Nutr. 2010, 104 (11): 1586-1600. 10.1017/S0007114510004010.CrossRef Ramsden CE, Hibbeln JR, Majchrzak SF, Davis JM: n-6 fatty acid-specific and mixed polyunsaturate dietary interventions have different effects on CHD risk: a meta-analysis of randomised controlled trials. Br J Nutr. 2010, 104 (11): 1586-1600. 10.1017/S0007114510004010.CrossRef
29.
go back to reference Lands B: Planning primary prevention of coronary disease. Curr Atheroscler Rep. 2009, 11 (4): 272-280. 10.1007/s11883-009-0042-6.CrossRef Lands B: Planning primary prevention of coronary disease. Curr Atheroscler Rep. 2009, 11 (4): 272-280. 10.1007/s11883-009-0042-6.CrossRef
Metadata
Title
Using 3–6 differences in essential fatty acids rather than 3/6 ratios gives useful food balance scores
Authors
Bill Lands
Etienne Lamoreaux
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Nutrition & Metabolism / Issue 1/2012
Electronic ISSN: 1743-7075
DOI
https://doi.org/10.1186/1743-7075-9-46

Other articles of this Issue 1/2012

Nutrition & Metabolism 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine